Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Prostate Cancer Cells

PSA Drop Seen with New Prostate Cancer Drug

Half of a group of men with castration-resistant prostate cancer (CRPC) had biochemical responses to treatment with an investigational androgen receptor modulator, data from a preliminary clinical study showed.

During 12 weeks of treatment with galeterone, prostate-specific antigen (PSA) declined by at least 30% in 24 of 49 patients, 11 of whom had declines… PSA Drop Seen with New Prostate Cancer Drug   



Dormant prostate cancer cells may be reawakened by factors produced in inflammatory cells

Researchers in the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute discovered in pre-clinical models that dormant prostate cancer cells found in bone tissue can be reawakened, causing metastasis to other parts of the body. Understanding this mechanism of action may allow researchers to intervene prior to disease progression.

“Understanding how and why dormant cells… Dormant prostate cancer cells may be reawakened by factors produced in inflammatory cells   



hyperglycemia1 - testis1 - microscopic nephrons1 - nsaids1 - ischaemic heart disease1 - urinary disease1 - gross hematuria1 - methoxyflurane1 - eswl1 - microhematuria1 - membranous nephropathy3 - henoch-schönlein purpura1 - lupus2 - sexually transmitted disease1 - intensity modulated radiation therapy1 - utero surgery1 - lupus patients1 - high-precision surgical robot1 - bony pelvis3 - triage1 - university of british columbia1 - american society of clinical oncology1 - prevent pregnancy1 - lower urinary tract problems1 - stone disease prevention1 - moderate incontinence1 - asymptomatic bacteriuria1 - brachytherapy2 - diagnostic tools1 - wake forest baptist medical center1 -